These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 39124865)
1. Long Non-Coding RNA Ma F; Zhang B; Wang Y; Lou C Molecules; 2024 Jul; 29(15):. PubMed ID: 39124865 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1. Luo W; Li X; Song Z; Zhu X; Zhao S Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379 [TBL] [Abstract][Full Text] [Related]
4. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3. Chen J; Peng X; Dai Y Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485 [TBL] [Abstract][Full Text] [Related]
5. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
6. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer. Hong S; Yan Z; Song Y; Bi M; Li S Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509 [TBL] [Abstract][Full Text] [Related]
7. AGAP2-AS1: An Indispensable lncRNA in Tumors. Chen J; Wang B Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074 [TBL] [Abstract][Full Text] [Related]
8. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme. Tian Y; Zheng Y; Dong X J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205 [TBL] [Abstract][Full Text] [Related]
10. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related]
11. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918 [TBL] [Abstract][Full Text] [Related]
12. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway. Zheng Y; Lu S; Xu Y; Zheng J Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis. Zhong P; Hua H; Chen S; Zhu Z; Xie F Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192 [TBL] [Abstract][Full Text] [Related]
15. The Antisense long noncoding RNA AGAP2-AS1 regulates cell proliferation and metastasis in Epithelial Ovarian Cancer. Tingting Z; Xiaojing L; Xiaoyan T; Keqin H; Junjun Q J Cancer; 2020; 11(18):5318-5328. PubMed ID: 32742478 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Huang Z; Zhang M; Li J; Lou C Biomed Pharmacother; 2023 Jul; 163():114756. PubMed ID: 37105079 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma. Ren P; Niu X; Zhao R; Liu J; Ren W; Dai H; Chen J; Yan J; Li B; Shao Y; Bai Y; Han P Cell Cycle; 2022 Apr; 21(7):697-707. PubMed ID: 35113007 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and the EMT process in colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis. Li H; Guo S; Zhang M; Li L; Wang F; Song B J Gene Med; 2020 Nov; 22(11):e3250. PubMed ID: 32639657 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors. Bao Z; Zheng Q; Li L Am J Transl Res; 2021; 13(2):757-769. PubMed ID: 33594324 [TBL] [Abstract][Full Text] [Related]
20. E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis. Guo Z; Liu X; Shao H Dig Liver Dis; 2022 Jul; 54(7):878-889. PubMed ID: 34838479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]